MedTerraCBD.com and use coupon code LTH for the listener discount!
Visit LearnTrueHealth.com/cbd to listen to episode 300 with Jay.
IT'S HERE! Learntruehealth.com/homekitchen
Use coupon code LTH for the listener discount!
Check out IIN and get a free module: LearnTrueHealth.com/coaching
Join the Facebook group: LearnTrueHealth.com/group
We’re now in episode 420 and who better be on the show than Medterra CBD founder, Jay Hartenbach. In this episode, we caught up with Jay on how Medterra is handling the coronavirus situation and how they’re still able to produce and ship products to customers. Jay also talks about what Medterra has been up to, what studies they’ve participated in, and what products are in development.
[0:00:00] Ashley James: Welcome to the Learn True Health podcast. I’m your host, Ashley James. This is episode 420.
I am so excited for today’s guest. We have back on the show Jay Hartenbach who is the founder of Medterra CBD, my favorite clean CBD company. Jay, we had you all the way back in episode 300. We’re in the 400s now so it’s been a while since we had you on the show. I can’t wait to hear what’s happened since we’ve had you on the show, and also how your company is staying in business to supply us with the needed CBD we need to keep our sanity. Because it’s so great for anxiety. Hemp cannabis is so great for keeping people calm and helping them. It’s very medicinal. You have a very clean form of CBD that doesn’t trigger tests if someone were to go get tested for THC, which we talk about in detail in episode 300. I recommend listeners check that out.
Jay gives us a fantastic discount, gives the listener is 15% off by using coupon code LTH. So we can go to medterracbd.com and use coupon code LTH for the listener discount. Jay, welcome back to the show.
[0:01:38] Jay Hartenbach: Thanks for having me back, Ashley. I’m excited to be here.
[0:01:40] Ashley James: Absolutely. You are in social isolation. Your company has been making some major transitions for ensuring that everyone is safe, that your customers are safe when they receive your products, that your employees are safe. I’d love to go through all this information. Welcome back to the show. First of all, we’ll definitely hear what has been happening in the world of CBD since we had you on the show in episode 300.
Right now, I know that your company has been taking this really seriously—the Covid-19 really seriously. You guys are in Southern California. What is your company doing to create social distancing and to make sure that everything is sanitized so that everyone’s healthy—both your customers and your employees?
[0:02:37] Jay Hartenbach: Absolutely, yeah. I think companies have a huge responsibility here. As the founder and the CEO of Medterra, you can impart a lot of change with something that can be viral—literally viral. Even though we may only employ 70 or 80 employees, there’s a huge responsibility because those 70 or 80 employees if sick could go and infect a lot more people and create this cascading effect. We made the decision two weeks ago to shut down the office entirely.
We’ve sent all the employees home just except for the few fulfillment employees that we have that are now going to be leaving tomorrow. They’re going to just be able to go on permanent leave, basically a paid vacation which is it’s good for them. They’ve worked so hard over the last months. They more than deserve it. We’ve been able to send everyone home.
It’s been a huge transition for us as a company because we have been so close for the last three years and working with each other. You’ve got a lot of friendships that have developed. Now everyone being remote, we were really worried about just the productivity but just also the morale. There’s a lot of concern in the environment of what’s going to happen, what’s going to happen with the economy? It’s been really reassuring to see you’ve got employees that are tagging each other on social media and making them do challenges from their house. We’ve stayed really, really connected.
In some ways, I think we’ve actually become even more productive and the communication has been even better because you’re forced to do so. You can’t not communicate because the only way to do it is to actually send them a message or a video chat. We have made that decision. It’s great to see other companies also making the decision to shut down the office and send everyone home.
[0:04:25] Ashley James: So you have a 40,000 square foot office—I think you said—in Southern California. How are you doing fulfillment then if everyone’s going home? So if someone orders your products are they not going to get it for the next two months or how does that work?
[0:04:45] Jay Hartenbach: That’s a great question. The fulfillment staff that has stayed there really for the last two weeks, like you had said, it is a very big space so social distancing is very possible in the Medterra office when there are only six employees doing fulfillment. What we’ve also been able to do—and this just us growing and maturing as a company—is starting to work with other third-party logistics companies spread out throughout the United States.
Our business, fortunately, has grown a lot larger than even when we last spoke. So the need for these different warehouses across the United States is very important. They are very, I should say, prepared to handle these types of situations. Just like what we were doing in the Medterra office where every order that we were sending out we were just wiping down as an extra precaution.
For our customers, these third party logistics warehouses and companies that we work with throughout the US are doing the same. That just allows everything to stay and run smoothly. We work with three different shipping partners: UPS, FedEx, and USPS, so orders are going out on time and they’re being delivered. In some cases, actually being delivered faster because we’re moving some of that shipping to our East Coast warehouses as opposed to having to ship everything from California.
[0:06:00] Ashley James: Awesome. So everything is sanitized. You are paying your employees to stay home during this quarantine, which I love to hear that people are able to keep their jobs. They will, of course, be loyal to your company for doing that. You help them they’re going to help you. I love seeing that. You’re not just hanging them out to dry. What did you mean by challenges from home? Can you give me some examples of how your employees have been challenging each other from home?
[0:06:39] Jay Hartenbach: I think everyone’s seen the push-up challenge or tag a pup. That’s gone viral on Instagram and social media. Now, I’m starting to see employees saying where they used to have, at two o’clock, they’d go get a shot of expresso together to beat the afternoon slow down. They’re now doing it remotely. It’s just fun to fun to see it. We are fortunate enough that we’ve got a very nice gym in the office. Now that everyone is not able to use that, it’s the same thing. You got people tagging each other and making them do home workouts. It’s just funny. There are also the challenges of working from home. I think it’s not a true conference call when people are working from home unless one dog barks or you have one child in the background. That’s been fun just seeing everyone, what they look like at home.
Like I said before, it is just incredible. I think we are so fortunate to have employees that truly believe in what we’re doing as a company. That’s why it’s so easy to take care of them because they just are—whatever adversity we give them, the CBD industry just in general has had a lot of adversity. Obviously, this has thrown another layer of challenges on, and just seeing how the employees are responding is incredible. I sent a message actually out to the team earlier today and I said, “If we had to start from scratch, I have no concerns because this is the team that I would do it with.” I truly mean that. There’s a lot of great CBD companies, but I really think that the Medterra team, in particular, is a special group. I’m just excited to continue to work through them no matter what the challenges present themselves to be.
[0:08:30] Ashley James: Absolutely. In our first interview, episode 300, we talked about the quality of Medterra about how you really work hard to make sure that the hemp that you derived the CBD from is really high-quality and medicinal, doesn’t have pesticides, that you have a filtration system so that you extract the CBD without the THC. There’s a lot that goes into the production. Listeners can go back to episode 300 to hear about that. We also shared a really interesting story about—I think it was a friend’s father or grandfather who had Parkinson’s. When he took the CBD, his shaking reduced or went away when he took it. Any updates on him?
[0:09:22] Jay Hartenbach: Yeah, continues to use the product. Just so that we’re friendly with our friends at the FDA, certainly not endorsing it as a treatment for that. I can say confidently that he has included that in his daily regimen. Going back to that point of having employees really believe in the company, every one of our employees has some type of personal connection to CBD. Whether it’s a family member or a friend that has seen the benefits for themselves—individually seen the benefits. It’s really easy as a CEO of a company to motivate people when you already have that type of product. It’s exciting.
That’s one of the cases. Because of that case actually and a couple others we’ve created this Medterra Assists program where there’s people that—based on either a disability or just being older and on a limited income or any type of service member: so military, police, fire—we give a significant discount sometimes up to 50% depending on the condition so that they can get access to these products. Because even though we try to keep our products as fairly priced as possible, they still are expensive. Those cases make it worth it for us, so we try to help where we can.
[0:10:39] Ashley James: Absolutely. It’s an expensive process to go through to make a CBD isolate that is clean, safe, and healthy. You’re making a high-quality product, and sometimes you have to pay more for quality. You get what you pay for especially in this industry. I love that you’re providing a big discount for those who really need it but can’t afford it. That’s fantastic. It’s like you could almost create a charity program or something on the side.
What has happened in the last—I think it’s been about a year and a half since you’ve been on the show. What’s happened in Medterra CBD in the last year and a half? How have you guys grown? What kind of science, what kind of studies have come out? I’d love to hear what you guys are doing now.
[0:11:44] Jay Hartenbach: Absolutely. It’s a year and a half years. I think three or four years or maybe five years. So much has happened. When we talked last, which was like you said a year and a half ago, we were in a 3,000 square foot office. We had 10 employees working with us.
[0:12:03] Ashley James: It’s awesome.
[0:12:03] Jay Hartenbach: Now, like I said, we’re in a 40,000 square foot space. We have just under 80 employees working with us. It’s just been incredible to see that growth. A lot of it is compliments to the team in executing, but it’s also just being a part of such a fast-growing industry. When we talked about we really were focused on isolate, and we were really focused on CBD. That was our mission as a company.
Now, a year and a half later, CBD is still our primary mission, but what we’ve recognized as a company is that there are other ingredients beyond CBD that can be powerful. So our goal is not to deliver the best CBD product but just to deliver the best product in general. So we’re now working on really cool blends that take other natural ingredients to really enhance that efficacy.
We’re just launching this new gummy line right now where gummies can be a great way to deliver CBD because it’s in a friendly format. Customers and consumers like gummies. If that helps them get on a regular regimen, then I’m all in favor of it. Just not selling a CBD gummy that’s got high fructose corn syrup and is loaded with gelatin and isn’t vegan friendly. Ours are pectin-base and all have additional ingredients whether it’s our Keep Calm, or Sleep Tight gummy, or even our Stay Alert gummy. They all have these different ingredients that ultimately give a more efficacious product to the consumer, which is what they’re doing.
One of the realizations we’ve had over the last year and a half too is people aren’t taking CBD for the sake of taking CBD. At least not anymore. I think in 2017 and earlier, it was this cool hip product. People were taking it just to be on that cutting edge. At this point, people are taking CBD because they believe that it works and it can help them. That’s become our mission as a company, just to ultimately deliver the most effective product. Those products all do contain CBD, but how do we get there? It’s different blends as well as some of our new delivery methods like liposomes that we’re working on.
[0:14:09] Ashley James: And have enough CBD in them so it’s not like trace amounts just so you can say. I bought a deodorant and it actually really works. I’m really happy with this deodorant. I always buy 100% natural deodorants, but honest to God it says there’s CBD in my deodorant. I had to laugh so hard because I’m like, “Why do my armpits need CBD really?” It’s probably trace amounts just so they can say like, “This is a CBD deodorant,” and that’s not why I bought it. I mean there’s charcoal and coconut oil and all kinds of other stuff and baking soda and whatever. It works. It’s one of the best deodorant I’ve ever used, but just the fact that it has CBD in it just made me chuckle because it’s one of those things now, it’s gimmicky. You can put a trace amount of CBD in something and then, “Oh, it’s CBD. We could charge $10 more,” but you’re not doing trace amounts in these gummies. You’re trying to get as much CBD as possible into them?
[0:15:06] Jay Hartenbach: That’s correct, yeah. We just take that stuff for granted, but it is worth highlighting because there is just a wide variety of CBD products on the market. Our gummies, as an example, have 25 milligrams of CBD per gummy. Most gummy or CBD gummies on the market usually have 5 to 10 milligrams. So we’re anywhere from 5 to 2 ½ times stronger from a gummy standpoint. That just goes back to our belief in looking at the clinical data where really, at a minimum, if you’re ingesting CBD you’re starting to see effects and that 15 milligrams per serving and kind of going up from there. A 5 or 10 milligram gummy is great. I think that’s a good place to start, but we are very scientifically-driven. So we want to make sure that we’re putting efficacious amounts to the CBD and all of our products.
[0:15:55] Ashley James: Speaking of scientifically-driven, have you guys participated in any studies or any scientific papers? Has there been anything new in the last year and a half in terms of the science?
[0:16:15] Jay Hartenbach: Absolutely, yeah. That’s something that we’re actually very proud of. We just finished a study that’s in peer review right now with the Baylor College of Medicine. It was a combined study with Baylor as well as some local that’s in Houston. What we were studying was the effect of CBD both in naked format or the way that it’s taken now as well as a liposomal format, which we can talk about more. We compared the efficacy versus obviously a control. So as a five-arm, double-blind placebo-controlled study.
We were taking senior dogs that had not found any benefit from traditional arthritis medication. Their owners volunteered to participate in that study. We weren’t locking the dogs up. They went home with the owners every night. I was talking to the marketing team. They said, “You need to make sure that when you talk about this that you clarify that this was not an animal study where they’re locked up.”
[0:17:1] Ashley James: People would be knocking on your door so hard. I love that. When you said vets I thought you meant veterans, but you actually meant the doctors like veterinarians. That’s another thing you definitely want to clarify because I’m like, “Oh, the vets. They would really like this.” Coming back from war and having post-traumatic stress and then being given liposomal CBD and seeing how it affects them.
Okay. So this is pain and dogs, which I find funny that we have to do a double-blind placebo study because it’s not like the dog knows whether we’re giving it olive oil extract or CBD. The dog doesn’t know, but this just going to prove even more that it works. How would they measure pain in dogs? They’re not limping, they’re not yelping, they’re able to walk and run? How did they measure the effects of CBD on these dogs, these senior dogs with arthritis?
[0:18:18] Jay Hartenbach: Well, that’s a great point. So the reason the double-blind was required was because we use something called the Helsinki Pain Index, which is an internationally recognized way of scoring animal behavior specifically to dogs. Like you said, it ties to their gait, how quickly they can go from sitting to standing, and then standing to laying down, and just this qualitative score. That double-blind placebo-control is really important because we don’t want the vets that necessarily know which dog is receiving the CBD or not CBD, but also throw the owners as well. If you’ve got an animal or a pet that’s in suffering, it breaks your heart. You’re really looking for any glimmer of hope. Maybe they get up a little bit faster than they usually do and you’re like, “Oh my God it’s working. This it.”
So it was very important for us just to make sure that it was completely double-blinded so that there wasn’t any way of misconstruing the data because it was a qualitative as opposed to a quantitative scoring system. We were looking at, like I said, how they were getting up and how they’re moving. What was really exciting was in the arm of the study where we were giving—these were larger dogs so 80-pound dogs. We were giving them 50 milligrams a day.
What we were doing was also looking at their liver profile to make sure that there weren’t any elevated liver enzymes, as well as looking at their red and white blood cell counts, as well as kidney analysis just to make sure that there was minimal side effects if not any side effects. In that one arm, 80% of the dog saw 50% improvement or more. This is on a 30-day study, which for us—I think anyone that’s familiar with clinical trials or any type of kind of medical research—30 days is lightning fast. So to see that type of result in 30 days, then we did a follow-on study 30 days after they completed a treatment just to see how quickly they would revert back to their previous symptoms. It was really encouraging to see. That study is in peer review. Go ahead.
[0:20:35] Ashley James: I was just going to say, so to clarify, how many dogs were in the study?
[0:20:39] Jay Hartenbach: There were 25 dogs total. We had five dogs in each arm.
[0:20:44] Ashley James: Okay. When you said each arm there was a placebo, so five dogs were not getting anything?
[0:20:52] Jay Hartenbach: Correct. Five dogs were in the control, five dogs were in the 20 milligrams of regular CBD oil, and then the third group was 50 milligrams, and then we did 20 milligrams of our liposomal delivery, and then 50 milligrams of our liposomal delivery. Each there was five, which is not a very large number. This is granted a preliminary study, but it was powered enough where we could see statistically significant results because of—
[0:21:22] Ashley James: Eighty percent of the dogs that received the CBD saw a 50% improvement. Was there a big difference in dose or did they—across the board no matter what the dose was—see an improvement?
[0:21:35] Jay Hartenbach: They did. The one group that received CBD that saw an improvement but not a significant improvement was the 20 milligrams of CBD oil. So non-encapsulated in a liposome. The one comment that we have to make on that is obviously these were larger dogs, so the average weight was 80 pounds. So think of big labs. One was that enough CBD for them to be effective, and two, these were, like I said, severely arthritic dogs that I don’t think we’re necessarily having the run of a mill arthritis or just age-related conditions.
In that 50 milligram arm of just receiving plain CBD oil, so just our Medterra Pet CBD oil 50 milligrams a day, so 25 in the morning and then 25 at night, that’s where that 80% saw 50% improvement or more. That’s something that I’d be happy to share. Like I said, it’s in peer review right now. We are hoping to publish in the next month or so. So we’re excited about that.
[0:22:42] Ashley James: Very cool. That’s great. So you followed up a month later. How are the dogs doing?
[0:22:49] Jay Hartenbach: Yeah. So a month later is a little bittersweet. For the dogs that were receiving just a regular CBD oil, it was this little heartbreaking because the owners are like, “I need to put them back on CBD as quickly as possible.” The dogs were obviously not very happy from seeing this huge reduction in their symptoms, and now all of a sudden reverting back over the course of really 15 to 20 days to start showing the same symptoms that they were having prior to starting the study.
All of the dogs that completed the study though are now receiving free Medterra CBD for life. It was a tough 30-day period after this study, but now they’re all receiving their CBD and they’re all taking it What was really fascinating for us and this what’s leading us to do some additional studies and actually talking about vets in the sense of veterans, the liposomal delivery, which is a way of encapsulating the CBD so that it becomes hydrophilic and non-hydrophobic, but also dramatically increases the bioavailability as well as the length of time that it is biologically active in the blood.
We were seeing 30 days after still some of the symptoms coming back but significantly reduced. That was very encouraging. I was joking with someone. Someone said, “I don’t know if that’s a great product for you guys to be selling. You’re going to put yourselves out of business.” Look, at the end of the day, we truly believe it. If we’re helping people and animals, then ultimately we’re going to have a strong company. If we ultimately can help them take less CBD down the road, then that’s great because that means they’re seeing less symptoms.
[0:24:33] Ashley James: I think it’s fantastic. You make a quality CBD product that ends up making it so that people need to take less and it lasts longer. Sure, they’ll buy less from you, but you’ll get more customers. Your goal has always been to help as many people as possible, and to make a high-quality product that is holistic, that is healthy, and healing. You’re on par with your mission statement. You’re not looking to try to get as much money out of everyone as possible. You’re trying to really help them. If you can make a very effective CBD product, then you actually would rise above the rest.
I love that you’re putting the effort and the money into all the science around it, which is what you talked about also in episode 300. Really interesting. I love that those dogs are on Medterra CBD for the rest of their life. I thought that was really cool. Why does CBD help to reduce pain especially in an instance where maybe it’s bone-on-bone? Obviously, CBD is not reversing arthritis, but it is significantly helping with pain. Is it that CBD blocks pain receptors, decreases inflammation? Do you know scientifically why CBD helps so much with pain?
[0:26:06] Jay Hartenbach: We’ve got a couple—I shouldn’t say guesses I think it’s a little more educated than a guess. That’s part of the ongoing research, but what we’re seeing is a couple of things. This is done with some of the lab work that we’ve partnered with Baylor to do. One, we’re seeing CBD actually bind directly to the neutrophils. So usually, in cases where you’ve got systemic arthritis, you’ve got overactive neutrophils that are part of our immune system that if operating and working properly these neutrophils are helping combat any foreign particles that are entering or foreign bacteria or viruses entering the body.
If you have an overactive neutrophil that’s basically attacking nearby cells that aren’t bad and they’re native to the body, then that’s a huge issue. What we’re seeing is CBD actually binding to these neutrophils and turning that activity down. That is one, going to just help arthritis in general because that can be a cause of arthritis. The second part of it is to just the actual inflammation around the body.
You’ve seen, we do have studies showing that CBD can turn down inflammation through a variety of methods in the body both applied topically and ingested. One of the things I think we talked about in episode 300 was if we look at just the human conditions that people are afflicted with, a vast majority of them have some tie-in to inflammation or that’s a GI issue, a dermatitis issue. If you can address just the root cause of that inflammation, then you’re going to ultimately see that benefit.
The actual mechanism and the pathway forward is really—I think actually under scrutiny right now—a lot of people have thought—this is new to the industry. Okay, you’ve got this endocannabinoids system. That CBD binds to CB1 and CB2 receptors, and that’s how it operates. We’re seeing, yes, that is part of the pathway for CBD to interact with the body, but like I said, you’re seeing CBD also bind with other parts of the body that aren’t tied directly to the endocannabinoid system. It’s almost creating a more holistic effect than what we thought.
The endocannabinoids system, it was really discovered and started being researched in the early 90s. To think that there weren’t going to be any revisions or new understandings on how it would work, I think was a little misguided or maybe too optimistic. We’re starting to find that out, and that’s exciting for us where you have CBD that’s actually binding to serotonin receptors in the brain. It’s not going through a CB1 receptor and then activating some type of cascade that then affects our serotonin levels. It’s actually just binding to the serotonin receptor in the cell.
That’s exciting for us. It’s just hinting at the potential of both CBD, but just all of these cannabinoids that we’re now looking at and starting to evaluate.
[0:29:12] Ashley James: You mention that CBD, they’re seeing now that it binds to neutrophils, that it’s part of the immune system. Are there studies that show that CBD helps us to combat bacteria or viruses?
[0:29:27] Jay Hartenbach: Yeah. That’s a great question as of late. CBD and just like you talked about your deodorant that has CBD in it. What is the actual justified use? CBD can be very helpful in helping our iMMUNne system from a variety of ways, but not necessarily directly. In the sense that we look at CBD and its ability to help people reduce any type of stress or potentially help with anxiety, those are both causes of immune system degradation. If you’re overly stressed, if you’re not sleeping well, then your immune system is going to start performing poorly. CBD has an immediate opportunity to be beneficial to the immune system through those pathways of just helping you be an overall healthy.
Medterra right now, we actually are developing, and we’re going to be launching this shortly—an Immunity Tincture. It has CBD in it because of those properties that I just described, but it also has Echinacea and elderberry in it to directly act on the immune system to boost the immune system. So kind of goes back to that mission of ours where we want to use CBD where CBD is very important to us, but we’re also not ignorant to the other ingredients that we could potentially include to get this more holistic, more ultimately efficacious product.
There is one cannabinoid though. I’ve heard CBG as an example that may have some antibacterial and antiviral effects. There’s a lot more work that needs to be done on that, but that is really interesting to see that there is one cannabinoid specifically that has shown some antibacterial properties, which is exciting.
[0:31:16] Ashley James: Back when I interviewed you in episode 300 your CBD has been filtered so that there’s no other cannabinoids, there’s no other—what’s the word—particles from the cannabis plant or the hemp plant.
[0:31:36] Jay Hartenbach: Yeah, cannabis.
[0:31:37] Ashley James: There’s the terpenes and all that stuff. It’s not in there, it’s only CBD and that’s great for postal workers, and flight attendants, or policemen, and people that have to take drug tests, or construction workers. They have to take drug tests. I remember my husband was a foreman union carpenter for 20 years. There was drug testing. When CBD came on the market he was worried about taking it. He wanted to try the CBD, which doesn’t get you high. Kids can take it safely. Like you said, pets can take it safely. It’s not a drug. It’s not a street drug. It’s not going to get you high. He really wanted to take it, but at the state at the same time, there wasn’t any CBD product that would say this is not going to trigger a drug test. When he was a union foreman union carpenter, if he were to have an accident let’s say like cut himself, if you have any accident on the job, they immediately require you to get a drug test.
I just remember his conflict because he really believed in all the information coming out and really wanted to try it. He had always had anxiety. He was looking for more natural ways of handling it. Then, of course, the anxiety of, “Well, if I take this CBD what if I have to do a drug test? What if it shows up positive?” That would give him anxiety. He was really just stuck in a hard place. Whereas you’ve solved this problem. That a policeman can take your CBD and know that it’s not going to trigger a drug test because it’s been isolated away from all the other elements of the plants that might trigger the test.
When we did speak in episode 300 we talked about all the medicinal benefits that are in the plant itself, because aside from THC and THCA, it’s the acidic form before it’s been heated. It doesn’t get you high, but it has medicinal properties. There are so many other cannabinoids in the cannabis and in the hemp plant that don’t get you high if processed properly, and that are medicinal and so healthy. There are now companies that want to make whole plant medicines. You were looking into that back then in the last year and a half. Have you made any headway or have you decided against it?
[0:34:27] Jay Hartenbach: Absolutely, yeah. To all those points that, Ashley, you just made one was a recognition. Even when we started Medterra there was this idea that when we looked at the medical research there was so much justification for having a CBD isolate because all of the medical research—specifically to CBD—was done on the isolate as opposed to a full-spectrum product. We felt confident that it was something that we could sell and feel like we were actually providing benefits.
Even since the beginning of Medterra, we never were wanting to dismiss the other properties of these cannabinoids because while CBD could really do a lot of the heavy lifting, I think it would be crazy to think that other parts of the plant couldn’t be beneficial. We just talked about CBG potentially having some antibacterial or antiviral effects.
To your point, one of the things that we had been exploring was this broad-spectrum component. As a company, Medterra really will never sell a product that has THC in it, but to your point, maybe there’s a way of including other parts of the plant like the terpenes, and the flavonoids, and the other cannabinoids besides THC to get more of a holistic encompassing effect.
We have actually recently launched a broad-spectrum product. It’s something that we’re really proud of because we’ve been working on it for a while. There’s a lot of broad-spectrum products out there and some are really good. So I want to make sure I clarify that. We don’t only have the good one, but a lot of broad-spectrum products use a manufacturing method very similar to ours to produce our isolate.
The way that they get rid of the THC is by just simply adding more and more isolate back into the full spectrum blend. If you add enough isolate into your full spectrum blend that might be let’s say 60% CBD and has 3% THC right when it leaves, obviously, the distillation. You just continually bombard it with more and more isolate, then eventually you’re going to get to the THC level will be to a non-detect amount, which is great. You now may not be free of THC, but you’ve got it at such a low level that people shouldn’t be concerned.
The downside is that you’ve basically also diluted everything else out of that full spectrum blend except for the CBD. Now you’re just selling hemp-flavored isolate, which I think is a disservice to people.
[0:36:53] Ashley James: A lot of companies are doing that. You go to the drugstore or you buy online, that’s what you’re getting.
[0:37:01] Jay Hartenbach: Exactly. That’s unfortunate. Just like when we’re talking about when we last spoke, if there’s any time you have any concern, any reputable CBD company should be able. One, they should have it on their website, but two, if you call them into their customer service line or send them an email, should be able to provide any CoA from any batch that you’ve purchased. You can quickly ascertain, “Okay. Are they doing this hemp-flavored isolate where they’re just diluting everything out?” You’ll know because you’ll see CBD concentration really high and then everything else will be non-detect, which like I said, doesn’t necessarily do you any good. You should just buy CBD isolate. It’s going to be cheaper.
With that being said, there have been some advances in the actual processing. Through this process of using chromatography where we’re able to selectively isolate out a compound. Instead of saying, Look, we’re going to isolate for CBD and leave everything else behind.” What we’re going to do is actually take this entire full-spectrum blend and just pull out the THC. You can do that through a process called chromatography. Even when we talked last time, it largely wasn’t scalable for the CBD industry.
You could produce maybe two or four kilos at a time or even the best labs. If you’re trying to put that on a national level, that’s just not going to scale, but some of the more recent advances have really allowed that to scale. You’ve got a lot of labs that are now operating in a much larger level.
Now that we are confident that it is a true broad-spectrum product, we’ve actually brought it to market. Our target for these broad-spectrum products is to really have anywhere from 10:20, 20:1 CBD:my inert cannabinoid ratio. It is meaningful. It’s still very largely a CBD product, but you have meaningful amounts of CBG, and CBC, and CBN all showing up on the COA. Not only in the bulk format but in the actual finished product format so that consumers are actually getting that benefit.
That’s been great for us because it’s really allowed us to branch out. The broad-spectrum products have quickly become a favorite of a lot of our customers where they love the CBD products, but getting those extra cannabinoids in there certainly isn’t hurting them, and for a lot is helping them. So that’s been exciting for us.
[0:39:25] Ashley James: Yeah, no kidding. What was the process, chromatography? How does that work?
[0:39:32] Jay Hartenbach: Knowing that you’ve got different molecular weights for all the cannabinoids—and part of the issue of isolating them out and this why it hasn’t been largely scalable is because the molecular weights are so similar. The compounds themselves are just very similar. It’s very difficult to isolate. Using a chromatography, you basically create these call it chemical filters or chemical gradients that allow basically the different densities of the compounds to sift through this filter.
What it creates is this almost imagine a flowing tap—for illustrative purposes. You put the material through in the beginning, and then what comes out first will be let’s say CBD. Then as you go to a different molecular weight then it’s CBG. Then a different molecular weight it’ll be CBN. Then the next molecular weight that passes through the filter based on the different densities will be THC.
You just note, “Okay. Based on what’s coming through on your testing you’re kind of pulling samples. Okay, this is the THC part of it. We need to just discard that, and then we can continue to last the rest of the flavonoids and terpenes flow through. They each come out individually and then you recombine them at the end and. It basically reconstitute that full-spectrum blend just without the THC.
[0:40:57] Ashley James: Fascinating. Do they take the THC and go sell it as a concentrate?
[0:41:05] Jay Hartenbach: I can’t tell you how many times I’ve got that question. We’re just talking with one of our distributors and they said, “Just let me know as a friend where they discard it.” No, they destroy it. It’s just a part of the federal regulations.
[0:41:20] Ashley James: Oh, man. They could have made such a great—I don’t know. I just think I live in Washington and they sell stuff here legally. I will just be like, “Hey, that’s like a byproduct that they could turn around and sell to people that want it,” I don’t partake anymore. I’m from Canada. All Canadians in the 90s grew up on pot. I prefer to be sober. I actually prefer. I don’t drink alcohol. I prefer to just have my wits about me. I’m not against anyone that chooses to partake. It’s just I like being in my body.
I’m a Pisces. I’m so ungrounded and so like in the ether as it is. I just like to be grounded as much as possible and have my wits about me. I see that it’s in Washington State, people partake. I think it’s a healthier alternative than drinking alcohol, to be honest.
People don’t smoke a joint and then start a bar fight and kill people. They usually just chill out, whereas alcohol, alcohol tends to cause more accidents and more violence in general. Your product does not contain anything that would make someone high. Can children take it or is there a warning that children aren’t allowed to take it? How does that work?
[0:42:54] Jay Hartenbach: That’s a great question. We do have parents buying it for their children and taking and giving it to their children. We’ve had a couple of parents say that it’s helping their child focus more, be less hyperactive. So children are taking it. It’s just like anything. When you’re talking about children, or pregnant women, or any of that, it’s just making sure that whatever y our primary care physician or anyone that has some medical experience to just make sure that they’re in the loop.
There haven’t been a lot of studies just because CBD is so new. We’ve talked about there is an endocannabinoid system in every mammal. Whether you’re a newborn or you’re 80 years old, CBD has the ability to interact with your body however it may do that. Especially with really young children, as children get into their teens, then you don’t have as much concern. That’s just something that you want to watch very carefully.
You’ve got children that are obviously taking it for the treatment of epilepsy with Epidiolex. They’ve done a lot of safety studies on these children. Looking at their liver and making sure that it wasn’t toxic to their liver in really high doses. That doesn’t seem to be a big safety concern, but at the same time, I think anytime you’re giving something to your children you’ve got to make you’re really educated. If you’ve got any questions, we’re here to help. Certainly, your physician should be able to help guide that conversation.
[0:44:39] Ashley James: Absolutely. That makes so much sense. I know of a few epileptic children who have completely been able to—and these were the ones that weren’t responding to drugs. Using cannabis, using CBD they, were able to reduce. In one instance, one person completely eliminated their seizures. That’s very interesting. I’ve had several doctors on the show talk about this. That our body has the endocannabinoid system. We have receptors for cannabinoids, and our body makes cannabinoids. So essentially our body’s making CBD. Because we’re nutrient deficient, so let’s say Omega 3s, whatever fatty acids our body uses to make these endocannabinoids.
When we are deficient in certain healthy fats our body can’t make enough of it, and then we become deficient in them. Then when we take an external CBD, it is like filling the nutrient deficiency. It’s a nutrient we’re deficient in. Those people that gain great benefits, so they take the CBD and they notice that they’re happier, calmer, significantly less anxiety, they’re able to focus, that they have better sleep, that they’re in less pain.
Those people had nutrient deficiencies and fatty acids to the point where their body wasn’t making. Their own endocannabinoid system was deficient, so now they’re fulfilling it. Some people take CBD and they don’t notice anything. Well, maybe they don’t have anxiety, they don’t have pain, and they don’t have problem sleeping. They were kind of surprised, “I took it. I didn’t notice anything.” Well, maybe they’re not deficient. So they took it, but the CBD didn’t need to fulfill. There was no nutrient deficiency for that person.
It’s not that CBG doesn’t work, it’s that it really works for people who are nutrient deficient, and many people are. Many people don’t have enough of those healthy fatty acids because we’re eating the wrong fats. We’re eating polyunsaturated fatty acids. That’s the majority of our diet, especially in the United States. So we’re getting the wrong fats, which are clogging everything up instead of the right fats that we can use, that our body can use to fulfill the endocannabinoid system.
Your CBD supplement is literally a supplement that’s fulfilling a deficiency, which is what these doctors are saying. I find that to be really fascinating especially when we look and see that some children react really well to it. Of course elderly and everyone in between. This deficiency doesn’t discriminate against age because it’s about whether we’re consuming, digesting, and absorbing enough nutrients.
This is what these doctors are saying about CBD. So we can really see it as a nutrient that is necessary for our body and not something that’s recreational or something just that’s cute and fun and, “Oh, that’s interesting.” It’s an essential nutrient the body actually needs.
[0:48:10] Jay Hartenbach: Totally. I couldn’t agree more. That’s one thing that really has to be communicated, that endocannabinoids system like you said. An endo-cannabinoid, as an example, is anandamide, which is a very similar analog to CBD. So if your body’s not producing that, like you said, because you’re not getting the right fats in your body, they’ve linked omega-3 deficiency with the inability to produce endocannabinoids as an example, then you’re going to need some type of supplement. Going back to the earlier point of if we ultimately sell less CBD because people are healthier, then that’s okay because we’re going to get more customers. I don’t think the world is going to have a shortage of people that are not nutrient deficient or need to be healthier.
If we can help people on their health and wellness journey, get a little bit more healthier then I think that’s awesome. That’s just a huge win for us as a company. We’re going to start understanding that even more as we do more research. Like everything in the body, it’s never black or white. It’s always something connected to another thing. There’s never a one fix-all. You could take a ton of CBD, but if you’re sleeping two hours at night, you’re probably not going to be a very healthy person. You sleep eight hours at night and you eat McDonald’s for lunch every day.
It’s all about balance and making sure that you’re in touch with your body. I love what you said about just being grounded in general. Because when people have more self-awareness of what’s going on in their body, then they can find even more effective treatments because they know exactly what issue they need to address.
[0:49:47] Ashley James: Wonderful. It has been about a year and a half, and you’ve talked about some exciting things. Is there anything in the CBD industry that’s come out that really surprised you? Because you have been so deep in this information. Has anything surprised you recently about CBD? Any new studies that have shocked you?
[0:50:14] Jay Hartenbach: New studies that shocked me, let me think on that. We talked about this. What we understand of the endocannabinoid system is going to be turned on its head, a little bit at least. That’s not for the worst, I think that’s just us understanding it better. The endocannabinoids system is going to continue to be very important, but just know that CBD isn’t limited to just these CB1 and CB2 receptors I think is relatively groundbreaking for scientists because they’ve been so closely looking at CB1 and CB2 receptors.
What’s going to be really groundbreaking, maybe we talk in a year and a half—hopefully, it’s much sooner—it’s these other cannabinoids that are now coming to light. They’re becoming feasible to put into products. Early studies of CBG I thought were pretty groundbreaking and showing that it could be antibacterial. That it’s actually helping. I saw some studies out of the UK that it shows that it’s actually helping with cancer.
That’s really on the forefront. Everyone has this sneaking suspicion that we’re just scratching the surface, and it’s great to see those finally come to light. I think shocking just in the CBD world in general, what we’re seeing is the FDA finally coming on board. We’re kind of shocked by how long it took the FDA. It’s one of those things where I totally respect what the FDA is doing. They need to do it in a systematic way so that they’re not doing it incorrectly or leaving any loopholes, but the longer they take to act the more time unscrupulous companies can exist.
We’re very careful when we’re talking about medical claims and making sure that we have our products manufactured correctly. It’s hard to continue to stay and compete and do well when you have some guy that’s mixing it up in his garage and he’s saying that it’s going to be the end-all-be-all.
Medterra is doing fine, but it’s that has been shocking because ultimately, the FDA can do a lot of good by being very clear on future guidelines of CBD and really forcing the bad actors to either clean up their act or get out of the industry.
[0:52:34] Ashley James: Yeah. We have to be careful about the claims that these companies make. It’s kind of the Wild Wild West, isn’t it? We want good regulations but at the same time, the FDA is a revolving door for pharmaceutical companies. They’re threatened by CBD because it’s cutting into their profits because people are getting off of pain meds or reducing pain meds. That reduces their profits.
I’m always leery. On one hand, we want the FDA to protect us, but on the other hand, we don’t want them to take away our right to access it. That’s why the FDA does not regulate supplements. There are laws. You can’t make health claims.
I can’t say, “Buy my vitamin C. It cures XYZ disease.” You can’t make health claims and make a profit off of something. If I was a doctor, I could say, “Vitamin C cures scurvy,” and that would be legal. But I couldn’t say, “My vitamin C brand cares scurvy. You should buy it.” There are laws around health claims and selling supplements, but as far as if the FDA regulated the supplement industry, they would do so in order to shut down many of the good companies that are out there. This is just getting into we need the Goldilocks. We need the balance. We need to be able to have good regulations, like you said, can get the bad actors to clean up or get out.
I’m always like just cautious because CBD is such a good product at reducing pain. It is cutting into the profits of the pharmaceutical industry. So I don’t want them to start regulating it to the point where it’s going to shut down good companies like you. Your company could lobby. Have you considered hiring some lobbyists to help Medterra and help the whole CBD industry? Is it to the point where we don’t need to lobby?
[0:55:00] Jay Hartenbach: No. There definitely need political action. Medterra, since really our existence, we’ve been a part of the U.S. Hemp Roundtable. This year, we actually just joined the Executive Board of the U.S. Hemp Roundtable. It’s a great advocacy group that works directly with politicians. It’s so interesting what politics being so polarizing. We are, as a group, working closely with Senator McConnell’s office and also working with Senator Schumer’s office. Depending on which side of the aisle you lean towards, one of those names might send chills up your spine.
[0:55:42] Ashley James: You need both sides to be on your side. You just need everyone to be on the side of CBD. It doesn’t matter. You just need all of them. Get as many of them as possible.
[0:55:54] Jay Hartenbach: That’s exactly it. They are. I guess it’s maybe a little biased, but I feel like the politicians in my mind are redeeming themselves. Because there’s this idea in America that some of the politicians can be very self-serving or just really only aligned with the party and not necessarily in with putting American citizens’ interests first. Them both working with each other, it kind of shows that look they are working towards a greater good. The new FDA Commissioner even said—I think it was a couple of weeks ago—said, “I would be a fool to think that I could outlaw CBD.”
We know what the future holds we just don’t know when. The first step that’s going to happen in probably sometime this summer, Congress is looking to pass a bill that will include language mandating that CBD is a dietary supplement. We think that’s going to happen in the summer with obviously an election year as well as obviously this international health crisis that we’re all facing. There’s some TBD on that, but ultimately that will pass. The FDA, like we said, is I think in favor of making CBD a dietary supplement. They just don’t want to create a policy.
One of the issues is this will be the first time that something has existed as a pharmaceutical product that then is now going to be sold as a dietary supplement. The reason this was set was in 2014 GW Pharma, right when it became legal, filed their IND for Epidiolex. So it became a pharmaceutical off the bat before anyone could even sell CBD as a dietary supplement. They’re selling it now.
The FDA does have some concern, not about CBD, but what other pharmaceutical drugs are now going to start being marketed as a dietary supplement, or what pressure are they going to face for other compounds not even related to CBD because of the precedent that they’ve set.
I don’t envy their job. I know people have this love-hate thing with the FDA, but I do believe that they are acting really in the best intention of making CBD as a dietary supplement. I think they’re on board with that. Allowing there to be some clear guidelines to kind of remove those bad actors, and then just freeing up these questions and concerns. You’ve got retailers like we work with, as an example, Albertsons is selling ingestible CBD products. Other retailers like CVS and Walgreens that we work with only carry the topical products because they’re worried about carrying the ingestible products. There’s just this confusion that ultimately is going to get cleared up.
In the meantime what we’re also working on that pharmaceutical front and talking about veterans, we actually are working on developing prescription or pharmaceutical products. We’re not using synthetic compounds. We’re using CBD and we’re encapsulating in our liposomal format, which we have a patent around. So that will be great because then we can actually allow doctors to prescribe and say, if the studies go well, and we’re talking a couple of years now, “You can take this product for X condition.” That also gives it a little bit more legitimacy as well.
[0:59:20] Ashley James: What you’re saying is that you’re liposomal CBD, which is not synthetic, you’re working towards having it be a prescription which would be paid for then by their health insurance. It wouldn’t be a drug, it’s not synthetic. It’s still naturally-derived and yet it would be a prescription, which would be amazing and be very helpful especially for veterans, and servicemen, and women, the elderly who are on a fixed income, or the disabled who are on a fixed income. That it could be paid for by the insurance companies. The insurance companies would be happy because there’s so much evidence that good quality CBD, especially liposomal, helps people reduce their need for pain medications, which would actually save these companies money.
These pain medications come with a host of side effects that then would cause the insurance companies to have to shell out more money. They’d be saving money by going the more natural route by paying for the prescription of liposomal CBD. That’s really exciting. When will we be able to access your liposomal CBD? When will we be able to buy some? Is there a date you have in mind for when it’ll be available to purchase?
[1:00:53] Jay Hartenbach: Yes. We will be launching it. One of the new lines that we’re launching is our Medterra Clinical Line. As a company, we’ve worked very closely with independent pharmacists across the country really since the beginning of Medterra. They’ve been a huge part of our business. We’ve actually developed what we call our Medterra Clinical Line. They are higher concentrations of our existing products as well as some new blends. That will be the first line to receive our liposomal products.
We’re developing a sleep product that has liposomal CBD but also has life is only melatonin, which is also not very bioavailable. We can dramatically reduce the amount of melatonin that we’re putting in it because it is in a liposomal more bioavailable format, which is just better for you. Then we’re also doing a wellness liposomal product that will have turmeric and ginger in liposomal encapsulation, which turmeric as an example, has a very hard time being absorbed by the body.
Those are launching in June—so this summer—in independent pharmacies. Then we’re going to be ultimately releasing those liposomal formats in the third quarter for just the entire company. People can buy that online as well. Really, really excited about it.
[1:02:16] Ashley James: Will you have a list of the independent pharmacies that we can drive to and pick up your liposomal products? Support the local companies or we just want to receive it faster, or do you have a list on your website?
[1:02:34] Jay Hartenbach: Absolutely. Yeah. We have a store locator. We’re actually updating the store locator now that we’ve got these different lines and products. You’ll be able to search on the store locator probably I’m going to say two weeks. I usually over-promise on website development.
[1:02:51] Ashley James: All your employees are at home so they should be even more productive.
[1:02:54] Jay Hartenbach: That’s true. That’s true. I will let them know that. In the next month or so you’ll be able to actually filter the store locator and say, “Hey, look. I’m looking for this specific, I live here and I want to buy this Medterra product.” They can validate if that store carries it. We work with—actually at this point—over 15,000 retailers throughout the US. Not all of them carry all of our products. It’s just helpful for consumers to figure out what they want.
We love working with the retailers because online is great. It’s a great business. It’s important to us as a company, but a lot of people when they want their CBD they want it now. So being able to get it and access it at a retailer relatively quickly is important. We’re thrilled with our retail footprint that we’ve developed.
[1:03:48] Ashley James: Nice. You know what, if listeners want to stay at home and get the package shipped to them they’re going to get 15% off by using coupon code LTH. They can’t walk to the pharmacy and say, “Coupon code LTH please.” So they’re going to get 15% off, and they get to stay at home and chill—Netflix and chill—and wait for their CBD to arrive. Coupon code LTH, 15% off on your website Medterracbd.com or they can go to your website and check out the pharmacy near them so that they can go there. I’m so excited about the liposomal CBD. That sounds amazing. Your turmeric will it have black pepper in it to activate the turmeric?
[1:04:33] Jay Hartenbach: That’s the thing. It won’t because it’s in the liposomal format—the black pepper is really helpful in increasing absorption because it slows down the digestion, but because it’s actually being not absorbed through the stomach and it’s actually hydrophilic, you don’t need the black pepper for the turmeric to be very bioavailable in a liposome.
[1:04:54] Ashley James: That’s really cool. It helps people because there are some people that are really sensitive to black pepper. That’s going to be great for them.
[1:05:03] Jay Hartenbach: We’re really excited. I’ve got some prototypes, and it’s my favorite Medterra product, not to rub it in for anyone that can’t get it yet. I think people are going to be really excited about it.
[1:05:14] Ashley James: I’ve got episodes I published four years ago that people still listen to. For someone who may be listening to this in a few months and they’ll be like, “Okay, I’m just going to go to Medterracbd.com and buy my,” what’s it going to be called the turmeric CBD liposomal thing?
[1:05:32] Jay Hartenbach: We’ve got a working name right now, but we’re calling it our Wellness Capsule.
[1:05:38] Ashley James: I love it. I love it. Wellness capsule. That is so great for decreasing inflammation, that’s great for autoimmune, that’s great for, obviously, pain. Turmeric is anti-cancer. It mops up those free radicals. You said that there was turmeric in it and obviously liposomal CBD. What was the other thing that’s in it?
[1:06:05] Jay Hartenbach: Ginger.
[1:06:06] Ashley James: Ginger, that’s right. Wonderful. Oh, man. What a powerful combination. I love how herbs create—when you combine certain herbs it creates a synergy like 1 plus 1 equals 10. It creates a synergistic effect. They individually are good but combined they’re amazing. Ginger turmeric is amazing together. Really interesting to see how CBD and those two play off of each other while giving healing effects to the body. You’re not deficient in CBD so you don’t see this huge difference like some people do when they start taking it, because obviously, you take your products. Why do you love the liposomal wellness capsule, the liposomal ginger turmeric CBD? Why do you love that? What do you notice personally in your body?
[1:07:02] Jay Hartenbach: It’s a great question. One, I think it’s great because if you’re taking CBD as a liposome it makes it more bioavailable. You’re just going to get more bang for your buck with this CBD. That’s a preferred format if available, but the ginger and the turmeric, same thing. I used to take turmeric capsules separate of my Medterra products and ginger. So just having that all-in-one is great. Liposomes are a tough thing to manufacture. So when we first started, we’ve been working on this at this point probably for thirteen or fourteen months now.
Liposomes, when you have things that are not very bioavailable, can be tough. Making a liposomal vitamin C is actually pretty straightforward. There’s a lot of it, but you’ve got something that’s incredibly hydrophilic. You put it right in the center of the liposome and you don’t have to kind of wedge it in between the phospholipid biolayer. You’re good to go. When you start mixing with ginger, which we use gingerall, which is the active form of the ginger or turmeric as an example it can start getting a little trickier.
I noticed—and there’s maybe some placebo effect but I think I’ve got it pretty adjusted—that when I take it as a liposome there’s this mood elevation. If you read a little bit about turmeric as an example, it has been associated with just general feelings of well-being and can elevate your mood. One, I’d love it just because it’s ginger and turmeric. Those are very important they’re very good for your body and making it more bioavailable is just only going to enhance those effects. Taking care of also the daily CBD that I’m taking. In addition also getting this more uplift in mood, which everyone can stand to be a little bit happier. That’s why I like taking it.
[1:09:03] Ashley James: Everyone can stand to be a little happier right now. Come on, Jay. Come on, Jay. Launch it sooner. We need it now. Right now, we’re all freaking out isolated at home getting bored and anxious. If we could choose one of your products, what would be the best one to choose right now to help us calm down?
[1:09:33] Jay Hartenbach: The Broad Spectrum Tincture and the best flavor, in my opinion, is the citrus flavor. So we’ve got a broad spectrum both 1000 and 2000 milligram concentrations. The 2000 milligram, obviously, has more CBD but also has more of those minor cannabinoids. We’ve got a lot of people that have said that it’s been very helpful with their stress relief. That’s just giving credit to these other cannabinoids that also are playing their part on the body.
[1:10:08] Ashley James: Okay. So we get the 2000. We got one bottle of the 2000 milligram Broad Spectrum, citrus flavor. We get it in the mail sanitized—you guys are great. Then how much do we take? Is it a few drops? Is it one dropper full? How much would we take throughout the day? Is it one dose a day? Is it throughout the day? How do we go about taking this? Let’s say it’s a person of average weight. Does weight matter like a 400-pound person versus a 90-pound person?
[1:10:40] Jay Hartenbach: It’s one of those things that we were just saying where it really depends on just the state of your body. We’ve seen people that are 250-pound man only needs 25 milligrams of CBD. You’ve got 140-pound woman that may need twice as much. So my recommendation on it is starting with half a serving, so half an ml, half of the dropper. Take it in the morning, and just see how you feel.
The other cannabinoids, they do seem to have some of a neurological effect as well. The one—I should say not to complain but just what people have said is that it does help them feel very relaxed. Depending on what your day looks like maybe feeling too relaxed is not what you need. Starting with half of it and seeing how your body reacts to it. Then maybe taking the other half at night. Just trying that for the first couple of days and then going from there. Some people take it as needed.
[1:11:44] Ashley James: A lot of us are stuck at home with our kids that we love dearly that are driving us up the wall. We really don’t need to start drinking wine at 9:00 in the morning, which a lot of people are sharing pictures of their alcoholic drinks on Facebook. My friend is stuck. He’s a psychologist or a psychiatrist. He and I were best friends in junior high. He lives in a condo in Toronto. He’s isolated at his condo so he started to make—it’s the best, it’s so hilarious—exercise videos with wine bottles. His pictures or videos of clips of him throughout his condo doing squats and bicep curls with wine bottles. Then other people have joined him. There’s just this group of people that are all doing the wine workouts. They’re just lifting wine. They’re not like working out drinking the wine.
Just making fun of the fact that everyone is freaking out. I saw someone posted a in a homeschooling group. “It’s 10:00 AM. Can I pop the bottle of wine now?” People are just freaking out especially if they’ve never homeschooled before. We’ve been homeschooling our son, who’s almost 5. It can get very stressful, so I can imagine if families have multiple children. They’re looking to just calm their nerves. This sounds great. So the Full Spectrum citrus flavor sounds like a great way to calm the nerves. I would say get the 2000 milligrams tincture because you don’t know if you need the more concentrated, the less concentrated. If you get the stronger one then you can always just take less of it. If you get the weaker one, you might run out sooner if you needed a stronger dose. Does that sound like a good recommendation?
[1:13:39] Jay Hartenbach: Totally. You do get a better bang for your buck. Even if you only need half it’ll last you longer, but it’ll also just be a better value for your spend.
[1:13:55] Ashley James: Nice, nice. Okay. Cool. Use coupon code LTH, get 15% off. So Full Spectrum 2000 milligram citrus flavor. Let’s all go buy that so we can calm down a bit. Take half of a dropper in the morning and see how we fare. Do we hold it in our mouth for a few minutes and then swallow, or can we swallow right away? What’s the way to maximize absorption? Should we do it on an empty stomach or with food?
[1:14:26] Jay Hartenbach: I know there’s been a lot of back and forth on that. Is it sublingual? We haven’t seen too many studies that have actually confirmed in an oil format that it’s able to penetrate in the mouth. I always wash it around my mouth for 10-15 seconds, but ultimately swallow it. We do recommend that people take it with some food because if you do have some food in your stomach it just helps it get to the liver and that will speed up. People have seen a lot of results taking on an empty stomach. It’s pretty resilient once consumed.
[1:15:08] Ashley James: Because it’s an oil format, if someone doesn’t have their gallbladder, for example, they should take it with some food and they should take a bile supplement to make sure they’re actually emulsifying it so that they can to digest and absorb it.
[1:15:24] Jay Hartenbach: Great point.
[1:15:26] Ashley James: There are some people who just—because they don’t have a gallbladder—cannot. They don’t have the ability to emulsify fat so they’re not really going to absorb the medicine. Those people would really benefit from the liposomal CBD, wouldn’t they?
[1:15:41] Jay Hartenbach: They would. Yeah. Absolutely. It doesn’t need to be processed in the liver, and it doesn’t need to be in an oil suspension.
[1:15:50] Ashley James: I’m really looking forward to that product coming out. Can’t wait for it. Awesome. Well, thank you, Jay, so much for coming on the show and sharing with us the latest. When I knew that the episode 420 was coming up I said, “Oh, man. Got to have Jay back on the show.” I’m only going to do episode 420 once and it needs to be one about hemp cannabis. It needs to be one of that. Obviously, everyone knows 420 and what that means. I was so happy that you were isolated at home and had nothing better to do than to be on my show. That was great.
[1:16:29] Jay Hartenbach: I just love that you thought of me for 420. I really do appreciate that.
[1:16:33] Ashley James: Yeah. You were the first thing that came to my mind. I’ve had other cannabis and hemp peep experts, but you probably are the funnest. Also just so interesting the fact that you’re so involved in the science, and in the industry, and in the latest coming out of the industry. That you’ve been in the cutting edge of how to create a full spectrum that is also void of THC is amazing. That your company is in the light. That you function in the light. That you show everyone that you are a company for good, and for light, and that you are not one of those shady companies that works in their garage and claims that they cure everything. You’re involved in the political side, the science side, the industry side, the production, side, the farming side.
You have your fingers in everything, but you also are navigating this crazy, crazy world of Covid-19 with your company doing it in the best way possible. Supporting your employees through this time. Everyone’s working from home, and your fulfillment staff is able to take a paid vacation, staycation. You’re able to keep the lights on because you’ve navigated this and figured out how to still fulfill the orders in a sanitized way to protect the customers. Really, I just love your company. I love the work that you do, and I love that you’re functioning in the light and for good. Thank you so much for the mission that you set out. If only a few years ago—when was it 2016—that you formed Medterra CBD?
[1:18:15] Jay Hartenbach: 2017.
[1:18:17] Ashley James: 2017. Oh, yeah. It was 2016 that you first started the conversation. It takes more than a year to get it all up and running. You’ve been functioning, you’ve been doing this for a few years, but you basically now earned your Ph.D. in CBD at this point. So congratulations. You now are a full-fledged Ph.D. in the school of hard knocks, you’ve earned it. It’s been great having you on the show. Thank you so much. I love your products.
My husband and I have really enjoyed your CBD. We’ve tried many others. We really get the quality is there. We really appreciate that. Of course, my listeners have told me that they really enjoy your products as well. I’m happy that you give us a 15% off discount. Thank you. Coupon code LTH. You talked about your conference calls having the dogs in the background. Well, I didn’t realize that my cat was locked in our office. He’s meowing. Your dog barked, my cat meowed. We’re clearly all at home under quarantine.
It’s been so great having you on the show. Thank you so much. Is there anything you’d like to make sure that you say to wrap up today’s interview? Is there anything left unsaid?
[1:19:42] Jay Hartenbach: No. I think we covered it all. Ashley, I really do appreciate the kind words. It means a lot coming from someone like yourself.
[1:19:51] Ashley James: Awesome. Well, Jay, can you just come back on the show every year and a half or so and update us on the latest in the industry? Or if something big comes out, some big science, something major in the industry that you really want to make sure we know about, please come back on the show. I love to keep all of us, all of the listeners—and myself included—up-to-date on all the really cool information about the CBD industry.
Keep coming back. We’d love to have you. Stay safe, stay sane. You were just talking about how you’ve been hiking because there’s a hiking trail right behind your house, but you, of course, stay a safe distance to respect everyone and everyone’s health. You are getting out in nature. If you can, everyone get out in nature as long as you’re safe and everyone else is safe. Get out in the sunlight. Get out in the open air.
Yes, we have a stay-at-home order. That doesn’t mean you can’t go in your backyard and get some sunlight on your face. We should all remember that for our sanity. We need to take deep breaths. We need to do things to calm our nervous system like taking CBD or putting our feet in the grass and our face in the sun and taking some deep breaths. We’re all going to get through this, and we’re all going to do it as a globe, as a whole. The whole earth, we’re all going to get through this together.
The more that we focus on self-care to boost our immune system and support our health overall our mental, emotional, and physical health overall. We will get through this in the healthiest way possible. We need to focus on that. You’ve brought up some great, great, great ways we can do that today. Thank you so much, Jay. Just stay safe and keep in touch.
[1:21:42] Jay Hartenbach: Absolutely. Will do, Ashley. Thank you so much.
[1:21:45] Outro: Are you in to optimize your health? Are you looking to get the best supplements at the lowest price? For high-quality supplements and to talk to someone about what supplements are best for you, go to takeyoursupplements.com and one of our fantastic true health coaches will help you pick out the right supplements for you that are the highest quality and the best price. That’s takeyoursupplements.com. Takeyoursupplements.com. That’s takeyoursupplements.com. Be sure to ask about free shipping and our awesome referral program.